Literature DB >> 19696174

ARMS2 is a constituent of the extracellular matrix providing a link between familial and sporadic age-related macular degenerations.

Elod Kortvely1, Stefanie M Hauck, Gabriele Duetsch, Christian J Gloeckner, Elisabeth Kremmer, Claudia S Alge-Priglinger, Cornelia A Deeg, Marius Ueffing.   

Abstract

PURPOSE: SNPs in chromosomal region 10q26 harboring PLEKHA1, ARMS2, and Htra1 showed the strongest association with age-related macular degeneration. Recent evidence suggests that in patients homozygous for the risk allele, the lack of synthesis of the poorly characterized ARMS2 is causative of this disorder. The present study was undertaken to gain an understanding of the genuine (patho)physiological role of this protein.
METHODS: ARMS2-interacting proteins were identified by using a yeast two-hybrid system and validated by coprecipitation. Immunofluorescence was applied to reveal the localization of ARMS2 in transfected cells and in human eyes. Western blot analyses were performed on extra- and intracellular fractions of ARMS2-expressing cells to demonstrate the secretion of ARMS2.
RESULTS: Contrary to previous reports, this study showed that ARMS2 is a secreted protein that binds several matrix proteins. Notably, ARMS2 directly interacts with fibulin-6 (hemicentin-1). Mutations in the fibulin-6 gene have been demonstrated to cause familial AMD. ARMS2 also interacts with further extracellular proteins, several of which have been implicated in macular dystrophies. Although ARMS2 apparently lacks any classic targeting sequence, it is translocated to the endoplasmic reticulum in cultured cells before secretion. ARMS2 is mostly confined to choroid pillars in human eyes, representing a part of extracellular matrix and corresponding to the principal sites of drusen formation.
CONCLUSIONS: The pivotal role of the extracellular matrix in the progression of AMD is underlined by the abnormal deposition of extracellular debris in the macula, observed frequently in affected individuals. The results have shown that ARMS2 may be necessary for proper matrix function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696174     DOI: 10.1167/iovs.09-3850

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  45 in total

1.  Copy number variations in candidate genes in neovascular age-related macular degeneration.

Authors:  Melissa M Liu; Elvira Agrón; Emily Chew; Catherine Meyerle; Frederick L Ferris; Chi-Chao Chan; Jingsheng Tuo
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-16       Impact factor: 4.799

2.  Repository of proposed pathways and protein-protein interaction networks in age-related macular degeneration.

Authors:  Fran M Pool; Christina Kiel; Luis Serrano; Philip J Luthert
Journal:  NPJ Aging Mech Dis       Date:  2020-01-07

Review 3.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 4.  Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis.

Authors:  Mohammad Hossein Jabbarpoor Bonyadi; Mehdi Yaseri; Mortaza Bonyadi; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2016-12-22       Impact factor: 2.031

5.  A novel ARMS2 splice variant is identified in human retina.

Authors:  Gaofeng Wang; William K Scott; Patrice Whitehead; Brenda L Court; Jaclyn L Kovach; Stephen G Schwartz; Anita Agarwal; Sander Dubovy; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Exp Eye Res       Date:  2011-11-22       Impact factor: 3.467

6.  Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome.

Authors:  Eunkyung An; Supti Sen; Sung Kyu Park; Heather Gordish-Dressman; Yetrib Hathout
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-05       Impact factor: 4.799

7.  Priorities and trends in the study of proteins in eye research, 1924-2014.

Authors:  Richard D Semba; Maggie Lam; Kai Sun; Pingbo Zhang; Debra A Schaumberg; Luigi Ferrucci; Peipei Ping; Jennifer E Van Eyk
Journal:  Proteomics Clin Appl       Date:  2015-09-16       Impact factor: 3.494

Review 8.  Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

Authors:  S Scott Whitmore; Elliott H Sohn; Kathleen R Chirco; Arlene V Drack; Edwin M Stone; Budd A Tucker; Robert F Mullins
Journal:  Prog Retin Eye Res       Date:  2014-12-05       Impact factor: 21.198

9.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

10.  Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy.

Authors:  Robyn Reynolds; Bernard Rosner; Johanna M Seddon
Journal:  Ophthalmology       Date:  2013-03-05       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.